Top-News

Novo-Nordisk Aktie (ADR) News

Aktie
WKN:  866931 ISIN:  US6701002056 US-Symbol:  NVO Branche:  Pharmazeutika Land:  Dänemark
47,86 $
-0,13 $
-0,27%
41,103 € 05.12.25
Depot/Watchlist
Marktkapitalisierung *
139,95 Mrd. €
Streubesitz
89,76%
KGV
27,28
Dividende
0,58 $
Dividendenrendite
1,22%
Faktor
1
Originalaktie
DK0062498333
Weiter abwärts? Short handeln - Jetzt mit Hebel 6,85: UQ24LH
Werbung

Novo-Nordisk Aktie (ADR) News

03.08.25 - PR Newswire
Faruqi & Faruqi Reminds Novo Nordisk Investors of The Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 30, 2025 - NVO
Faruqi & Faruqi Reminds Novo Nordisk Investors of The Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 30, 2025 - NVO PR Newswire
31.07.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO PR Newswire
10.07.25 - ARIVA.DE Redaktion
Novo Nordisk: Langsam müssen sich die Bullen mal ins Zeug legen!
Die Aktie von Novo Nordisk steckt nach einer zwischenzeitlich dynamischen Erholung in einer Konsolidierung fest. Zwar ist die Ausgangslage konstruktiv, aber allzu viel Zeit sollten ...
26.06.25 - PR Newswire
Novo Nordisk continues efforts to support patient access to authentic, FDA approved Wegovy® and prioritize patient safety
Novo Nordisk continues efforts to support patient access to authentic, FDA approved Wegovy® and prioritize patient safety PR Newswire
23.06.25 - PR Newswire
Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing
Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing PR Newswire
16.06.25 - inv3st.de
Novo Nordisk, dynaCERT, Verbio – Keine Panik!
Nein, diese Woche stand nicht Donald Trump im Mittelpunkt, obwohl der US-​Präsident anlässlich seines 79. Wiegenfestes zu einer Parade lud. Vielmehr prägte die kriegerische ...
22.05.25 - PR Newswire
New Novo Nordisk initiatives support patient access to authentic, FDA-approved Wegovy® as federal ban on mass compounding of "semaglutide" takes effect
New Novo Nordisk initiatives support patient access to authentic, FDA-​approved Wegovy® as federal ban on mass compounding of "semaglutide" takes effect PR Newswire
20.05.25 - PR Newswire
From Retina Scans to Cancer Trials, AI Is Taking Over the Exam Room
From Retina Scans to Cancer Trials, AI Is Taking Over the Exam Room PR Newswire
20.05.25 - PR Newswire
From Retina Scans to Cancer Trials, AI Is Taking Over the Exam Room
From Retina Scans to Cancer Trials, AI Is Taking Over the Exam Room PR Newswire
24.03.25 - PR Newswire
Novo Nordisk expands Wegovy® $499-per-month offering to additional cash-paying patients via the Wegovy® savings offer
Novo Nordisk expands Wegovy® $499-per-​month offering to additional cash-​paying patients via the Wegovy® savings offer PR Newswire
24.03.25 - PR Newswire
The Gross Law Firm Notifies Shareholders of Novo Nordisk A/S(NVO) of a Class Action Lawsuit and an Upcoming Deadline
The Gross Law Firm Notifies Shareholders of Novo Nordisk A/S(NVO) of a Class Action Lawsuit and an Upcoming Deadline PR Newswire
23.03.25 - PR Newswire
NVO Deadline: NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit
NVO Deadline: NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit PR Newswire
22.03.25 - PR Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk PR Newswire
21.03.25 - PR Newswire
Novo Nordisk A/S Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - NVO
Novo Nordisk A/S Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - NVO PR Newswire
20.03.25 - PR Newswire
Shareholders that lost money on Novo Nordisk A/S(NVO) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
Shareholders that lost money on Novo Nordisk A/S(NVO) Urged to Join Class Action - Contact The Gross Law Firm to Learn More PR Newswire
19.03.25 - PR Newswire
NVO Investors are Reminded of Final Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit with the Schall Law Firm
NVO Investors are Reminded of Final Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
18.03.25 - PR Newswire
NVO Deadline: NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit
NVO Deadline: NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit PR Newswire
18.03.25 - PR Newswire
Novo Nordisk A/S Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - NVO
Novo Nordisk A/S Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - NVO PR Newswire
17.03.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Lawsuit Against Novo Nordisk A/S - NVO
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Lawsuit Against Novo Nordisk A/S - NVO PR Newswire
17.03.25 - PR Newswire
Class Action Filed Against Novo Nordisk A/S (NVO) - March 25, 2025 Deadline to Join - Contact The Gross Law Firm
Class Action Filed Against Novo Nordisk A/S (NVO) - March 25, 2025 Deadline to Join - Contact The Gross Law Firm PR Newswire

Newssuche

Videos

newspaper
18:20 Uhr
Master the Trading!
In diesem Trading-​Webinar haben wir von A bis Z den Aufbau professionellen Tradings thematisiert und ... Mehr »